A detailed history of Valmark Advisers, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Valmark Advisers, Inc. holds 24,571 shares of MRK stock, worth $2.44 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
24,571
Previous 24,146 1.76%
Holding current value
$2.44 Million
Previous $2.99 Million 6.66%
% of portfolio
0.04%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$111.15 - $128.97 $47,238 - $54,812
425 Added 1.76%
24,571 $2.79 Million
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $64,128 - $68,873
518 Added 2.19%
24,146 $2.99 Million
Q1 2024

May 03, 2024

BUY
$113.24 - $131.95 $111,654 - $130,102
986 Added 4.35%
23,628 $3.12 Million
Q4 2023

Feb 02, 2024

BUY
$100.18 - $109.02 $2,604 - $2,834
26 Added 0.11%
22,642 $2.47 Million
Q3 2023

Nov 07, 2023

SELL
$102.95 - $114.33 $40,871 - $45,389
-397 Reduced 1.73%
22,616 $2.33 Million
Q2 2023

Aug 02, 2023

BUY
$108.61 - $118.38 $16,400 - $17,875
151 Added 0.66%
23,013 $2.66 Million
Q1 2023

May 01, 2023

BUY
$102.94 - $114.86 $25,735 - $28,715
250 Added 1.11%
22,862 $2.43 Million
Q4 2022

Feb 06, 2023

BUY
$87.44 - $112.11 $109,125 - $139,913
1,248 Added 5.84%
22,612 $2.51 Million
Q3 2022

Nov 02, 2022

SELL
$84.53 - $94.96 $8,453 - $9,496
-100 Reduced 0.47%
21,364 $1.84 Million
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $146,024 - $165,525
1,749 Added 8.87%
21,464 $1.96 Million
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $64,321 - $72,100
-875 Reduced 4.25%
19,715 $1.62 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $73,147 - $91,626
1,012 Added 5.17%
20,590 $1.58 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $28,600 - $31,453
-399 Reduced 2.0%
19,578 $1.47 Million
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $21,444 - $23,719
305 Added 1.55%
19,977 $1.55 Million
Q1 2021

May 04, 2021

BUY
$68.86 - $81.11 $122,157 - $143,889
1,774 Added 9.91%
19,672 $1.52 Million
Q4 2020

Feb 03, 2021

BUY
$71.77 - $79.65 $681,599 - $756,436
9,497 Added 113.05%
17,898 $1.46 Million
Q3 2020

Nov 09, 2020

BUY
$73.18 - $82.95 $14,928 - $16,921
204 Added 2.49%
8,401 $697,000
Q2 2020

Jul 31, 2020

SELL
$70.42 - $80.13 $30,984 - $35,257
-440 Reduced 5.09%
8,197 $634,000
Q1 2020

May 01, 2020

BUY
$63.36 - $87.82 $9,630 - $13,348
152 Added 1.79%
8,637 $665,000
Q4 2019

Jan 31, 2020

SELL
$77.58 - $87.54 $23,506 - $26,524
-303 Reduced 3.45%
8,485 $772,000
Q3 2019

Nov 06, 2019

BUY
$76.08 - $82.93 $12,248 - $13,351
161 Added 1.87%
8,788 $740,000
Q2 2019

Aug 07, 2019

SELL
$69.84 - $81.59 $18,856 - $22,029
-270 Reduced 3.03%
8,627 $723,000
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $20,178 - $23,014
-290 Reduced 3.16%
8,897 $740,000
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $2,152 - $2,498
33 Added 0.36%
9,187 $702,000
Q3 2018

Nov 02, 2018

BUY
$57.69 - $67.84 $173 - $203
3 Added 0.03%
9,154 $649,000
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $8,285 - $9,734
-163 Reduced 1.75%
9,151 $555,000
Q1 2018

May 07, 2018

SELL
$50.96 - $59.23 $28,486 - $33,109
-559 Reduced 5.66%
9,314 $507,000
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $509,644 - $608,571
9,873
9,873 $556,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Valmark Advisers, Inc. Portfolio

Follow Valmark Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.